Literature DB >> 34002474

Combined hepatocellular-cholangiocarcinoma - More questions than answers.

Richard A Hubner1, Helen L Reeves2, Julien Edeline3.   

Abstract

Entities:  

Year:  2021        PMID： 34002474     DOI： 10.1111/liv.14894

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  2 in total

1.  Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

Authors:  Xiaoyuan Chen; Yiwei Lu; Xiaoli Shi; Xuejiao Chen; Dawei Rong; Guoyong Han; Long Zhang; Chuangye Ni; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

2.  Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis.

Authors:  Xiaoyuan Chen; Shiquan Sun; Yiwei Lu; Xiaoli Shi; Ziyi Wang; Xuejiao Chen; Guoyong Han; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  Ann Transl Med       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.